Mer­ck pens pact with Pearl Bio for new bi­o­log­ics in can­cer

Mer­ck is team­ing up with a Khosla Ven­tures-backed biotech in a pack­age that could be worth as much as $1 bil­lion to cre­ate new bi­o­log­ics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.